| # | Drug | Count |
|---|---|---|
| 0 | FOLIC ACID | 8 |
| 1 | CARBOPLATIN | 7 |
| 2 | PACLITAXEL | 6 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 6 |
| 4 | ADALIMUMAB | 5 |
| 5 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 4 |
| 6 | ATAZANAVIR | 4 |
| 7 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 4 |
| 8 | RITONAVIR | 4 |
| 9 | RITONAVIR 100 MG | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 4 | 0.0006 |
| 1 | FELBAMATE | 1 | 0.0006 |
| 2 | MENOTROPINS | 1 | 0.0005 |
| 3 | FOSPHENYTOIN SODIUM | 1 | 0.0004 |
| 4 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 1 | 0.0004 |
| 5 | FENFLURAMINE | 2 | 0.0004 |
| 6 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 4 | 0.0004 |
| 7 | ATAZANAVIR | 4 | 0.0003 |
| 8 | RITONAVIR 100 MG | 4 | 0.0003 |
| 9 | DOLUTEGRAVIR SODIUM | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |
| 1 | Protease Inhibitor [EPC] | 4 | 0.0001 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 4 | 0.0001 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0000 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Microtubule Inhibitor [EPC] | 6 | 0.0000 |
| 7 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Vitamin D [EPC] | 8 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 7 | 0.0000 |